CN1161216A - Medicines for treating bone tuberculosis, osteomyelities medullitis and other swelling pain - Google Patents
Medicines for treating bone tuberculosis, osteomyelities medullitis and other swelling pain Download PDFInfo
- Publication number
- CN1161216A CN1161216A CN96115726A CN96115726A CN1161216A CN 1161216 A CN1161216 A CN 1161216A CN 96115726 A CN96115726 A CN 96115726A CN 96115726 A CN96115726 A CN 96115726A CN 1161216 A CN1161216 A CN 1161216A
- Authority
- CN
- China
- Prior art keywords
- hair
- vegetable oil
- olibanum
- medicines
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invented medicine is composed of dried venom of toads, crucian carp, croton, caster bean, frankincense, hair, twig of scholartree and matrix, Efficacy: promoting blood circulation and removing blood stasis, moistening the skin and stopping pain,d rawing out pus and subsidence of swelling, removing the necrotic tissue and promoting granulation. When using, it is made into plaster and applied to the affected part. It can make the affected part heal quickly and alleviate patient's suffering andfeatures quick in curing effect, endurance of efficacy, high cure rate, uneasy recurrence, convenient for using and toxic side effect free.
Description
The invention belongs to a kind of medicine for the treatment of bone tuberculosis, osteomyelitis and other diseases of swelling and ache.
At present, treatment bone tuberculosis, osteomyelitis (co) mostly use Western medicine or adopt the method for operative treatment, and these methods all are difficult to cure above-mentioned disease, though have to cure relapse rate high, also can stay sequela.Especially the patient will should bear huge financial burden through for many years even the treatment of decades, the inconvenience that standing again takes medicine for a long time brings, and also final most of patient still will bear the misery of amputation.
The purpose of this invention is to provide a kind of medicine for the treatment of bone tuberculosis, osteomyelitis and other diseases of swelling and ache, with diseases such as this Drug therapy bone tuberculosis and osteomyelitis, therapeutic effect is good, cures the back and is difficult for recurrence.
Feature of the present invention is to contain following composition: Venenum Bufonis, Carassius auratus, Fructus Crotonis, Semen Ricini, Olibanum, hair, Rumalus sophorae and substrate; By its weight percent meter, the 7-42% surplus that Venenum Bufonis, Carassius auratus, Fructus Crotonis, Semen Ricini, Olibanum, hair and Rumalus sophorae account for total dose is a substrate.
Among the present invention, the weight percentage of Venenum Bufonis, Carassius auratus, Fructus Crotonis, Semen Ricini, Olibanum, hair and Rumalus sophorae can respectively account for 1-6%.Hair can be selected animal hairs such as Pilus Sus domestica, Pilus Caprae seu Ovis for use, is people's hair preferably; The composition of substrate is vegetable oil and Hydrocerussitum (Ceruse), also can be vegetable oil and Plumbum preparatium, and wherein the amount of Hydrocerussitum (Ceruse) or Plumbum preparatium accounts for the 20-30% of total dose; Be Oleum sesami preferably in the vegetable oil.
The present invention can be made into plaster.The Venenum Bufonis of its use, Carassius auratus, Fructus Crotonis, Semen Ricini, Olibanum, hair and Rumalus sophorae be as monarch drug, adds Hydrocerussitum (Ceruse) or Plumbum preparatium, vegetable oil is refining forms, wherein Venenum Bufonis, Carassius auratus, Semen Ricini draw out pus by applying a plaster to the affected part, pain relieving, have one's ideas straightened out, effect such as detumescence; Fructus Crotonis, hair, Rumalus sophorae have the effect of dissolving blood stasis and detoxication; Olibanum has effects such as pain relieving, antiinflammatory, blood circulation and promoting silt; Vegetable oil, Hydrocerussitum (Ceruse) or Plumbum preparatium are the substrate of plaster, itself also have simultaneously the effect that softening diseased region, skin moistening are drawn out pus by applying a plaster to the affected part
The plaster that uses the present invention to make has special efficacy, and can treat all diseases of swelling and ache for treatment bone tuberculosis, osteomyelitis.Can be affixed on patient's diseased region during use outward, make medicine directly act on affected part, attack in the human body by skin pore, thereby reach the purpose of antiinflammatory, detumescence, removing the necrotic tissue and promoting granulation, poison drawing stagnation resolving, can make affected part healing rapidly and ease the pain, its curative effect is rapid and the efficacy of a drug is lasting, and is evident in efficacy and cure the back and be difficult for recurrence, through clinic trial, cure rate reaches more than 95%.Use the present invention to adopt the method for inner disease outer treat to reach therapeutic purposes, thus easy to use, and without any side effects.Because curative effect is fast, the cure rate height, thereby can alleviate patient's financial burden greatly.
The present invention is in the clinic trial process, and patient's 1453 examples of accepting hospitalization for medical treatment are bone tuberculosis patient 578 examples (male 342 examples, women 236 examples) wherein, osteomyelitis (co) 875 examples (male 513 examples, women 362 examples).Among the above-mentioned patient, 5 years old of age minimum, maximum 76 years old; Medical history is the longest 45 years, the shortest 20 days; Have 216 examples to belong to first visits and be in hospital, remaining 1237 example all is through the many places hospitalize and poor effect or outbreak repeatedly, and 413 examples have wherein been implemented operative treatment outside institute and operative incision can not heal for a long time.Above-mentioned 1453 routine patients cure 1392 examples altogether through trial edition invention treatment, and cure rate reaches 95.8%, the mean treatment time is 28 days, through following up a case by regular visits to, 58 people recurrence is only arranged among the patient of healing, relapse rate is 4.2%, and its cause of recurrence mostly be because administration time too short due to.
Use the present invention to treat bone tuberculosis and compare with the use prior treatment method with osteomyelitis (co), curative effect is very remarkable, and instant effect, and is painful little, efficacy consolidation.Using another significant advantage of the present invention is that expense is low, and its expense only is 26.23% of an other treatment method.Following table is for using prior treatment method with using the present invention to treat bone tuberculosis and myelitic Comparison of therapeutic table:
| Total cure rate | Recurrence rate after healing | The mean treatment time | |
| Use existing Therapeutic Method | ????72.4％ | ????24％ | 43 days |
| Use the present invention | ????95.8％?? | ????4.2％ | 28 days |
Embodiment 1-3 and 4-9 see the following form, and wherein the amount of each component is all by weight percentage:
Embodiment 1-3
Embodiment 4-9
| Sequence number | Component and content | |||||||||
| ??4 | Component | Venenum Bufonis | Carassius auratus | Fructus Crotonis | Semen Ricini | Olibanum | Hair | Rumalus sophorae | Plumbum preparatium | Oleum Arachidis hypogaeae semen |
| Content | ????1 | ????3 | ????2 | ????6 | ????4 | ????1 | ????5 | ???23 | ????55 | |
| ??5 | Component | Venenum Bufonis | Carassius auratus | Fructus Crotonis | Semen Ricini | Olibanum | Pilus Caprae seu Ovis | Rumalus sophorae | Hydrocerussitum (Ceruse) | Oleum Arachidis hypogaeae semen |
| Content | ????2 | ????1 | ????1 | ????2 | ????1 | ????5 | ????6 | ???30 | ????52 | |
| ??6 | Component | Venenum Bufonis | Carassius auratus | Fructus Crotonis | Semen Ricini | Olibanum | Pilus Sus domestica | Rumalus sophorae | Hydrocerussitum (Ceruse) | Oleum sesami |
| Content | ????5 | ????4 | ????5 | ????3 | ????2 | ????4 | ????4 | ???20 | ????53 | |
| ??7 | Component | Venenum Bufonis | Carassius auratus | Fructus Crotonis | Semen Ricini | Olibanum | Hair | Rumalus sophorae | Hydrocerussitum (Ceruse) | Rapeseed oil |
| Content | ????6 | ????5 | ????6 | ????1 | ????6 | ????3 | ????1 | ???25 | ????47 | |
| ??8 | Component | Venenum Bufonis | Carassius auratus | Fructus Crotonis | Semen Ricini | Olibanum | Hair | Rumalus sophorae | Plumbum preparatium | Oleum sesami |
| Content | ????3 | ????2 | ????3 | ????4 | ????3 | ????2 | ????2 | ???28 | ????53 | |
| ??9 | Component | Venenum Bufonis | Carassius auratus | Fructus Crotonis | Semen Ricini | Olibanum | Pilus Sus domestica | Rumalus sophorae | Hydrocerussitum (Ceruse) | Oleum sesami |
| Content | ????4 | ????6 | ????4 | ????5 | ????5 | ????6 | ????3 | ???21 | ????46 | |
Take by weighing spice by above-mentioned prescription, with plant fried juice, filtration, filtrate adds paste that Hydrocerussitum (Ceruse) or Plumbum preparatium powder, Olibanum be smelt the soft or hard appropriateness, makes plaster, when using after soaking, and it is softening that plaster is heated, be affixed on patient's disease sites and get final product, pasted the back drug effect sustainable 7-10 days.
Claims (7)
1, a kind of medicine for the treatment of bone tuberculosis, osteomyelitis and other diseases of swelling and ache is characterized in that containing following composition: Venenum Bufonis, Carassius auratus, Fructus Crotonis, Semen Ricini, Olibanum, hair, Rumalus sophorae and substrate; By its weight percent meter, Venenum Bufonis, Carassius auratus, Fructus Crotonis Semen Ricini, Olibanum, hair and Rumalus sophorae account for the 7-42% of total dose, and surplus is a substrate
2,, it is characterized in that Venenum Bufonis, Carassius auratus, Fructus Crotonis, Semen Ricini, Olibanum, hair and Rumalus sophorae respectively account for the 1-6% of total dose by its weight percent meter according to the described medicine of claim 1.
3,, it is characterized in that said hair is a hair according to claim 1 or 2 described medicines.
4, according to claim 1 or 2 described medicines, it is characterized in that said substrate is vegetable oil and Hydrocerussitum (Ceruse), by its weight percent meter, the amount of Hydrocerussitum (Ceruse) accounts for the 20-30% of total dose, and surplus is a vegetable oil.
5,, it is characterized in that said vegetable oil is an Oleum sesami according to the described medicine of claim 4.
6, according to claim 1 or 2 described medicines, it is characterized in that said substrate is vegetable oil and Plumbum preparatium, by its weight percent meter, the amount of Plumbum preparatium accounts for the 20-30% of total dose, and surplus is a vegetable oil.
7,, it is characterized in that said vegetable oil is an Oleum sesami according to the described medicine of claim 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96115726A CN1066334C (en) | 1996-04-03 | 1996-04-03 | Medicines for treating bone tuberculosis, osteomyelities medullitis and other swelling pain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96115726A CN1066334C (en) | 1996-04-03 | 1996-04-03 | Medicines for treating bone tuberculosis, osteomyelities medullitis and other swelling pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1161216A true CN1161216A (en) | 1997-10-08 |
| CN1066334C CN1066334C (en) | 2001-05-30 |
Family
ID=5122951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96115726A Expired - Fee Related CN1066334C (en) | 1996-04-03 | 1996-04-03 | Medicines for treating bone tuberculosis, osteomyelities medullitis and other swelling pain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1066334C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110708A (en) * | 2013-03-18 | 2013-05-22 | 刘长利 | External-use plaster preparation for treating hyperosteogeny as well as preparation method and using method of external-use plaster |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1095600A (en) * | 1992-11-26 | 1994-11-30 | 王璐林 | Bone regeneration pill |
| CN1108939A (en) * | 1994-02-20 | 1995-09-27 | 郑红梅 | Baidujing adhesive plaster and its preparation |
-
1996
- 1996-04-03 CN CN96115726A patent/CN1066334C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110708A (en) * | 2013-03-18 | 2013-05-22 | 刘长利 | External-use plaster preparation for treating hyperosteogeny as well as preparation method and using method of external-use plaster |
| CN103110708B (en) * | 2013-03-18 | 2014-07-30 | 刘长利 | External-use plaster preparation for treating hyperosteogeny as well as preparation method and using method of external-use plaster |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1066334C (en) | 2001-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Khorasani et al. | The effects of Aloe Vera cream on split-thickness skin graft donor site management: a randomized, blinded, placebo-controlled study | |
| CN101049337B (en) | Medication for curing furuncle, sore, and carbuncle, and preparation method | |
| CN102283887B (en) | Ointment for treating burn | |
| CN1066334C (en) | Medicines for treating bone tuberculosis, osteomyelities medullitis and other swelling pain | |
| CN103768388A (en) | Traditional Chinese medicine formula for treating scalds, burns and trauma by being singly applied externally | |
| CN101254277B (en) | External application paste for curing empyrosis | |
| CN100370998C (en) | Chinese medicinal preparation for treating sore, and wound and turn and scald | |
| CN102727698A (en) | Wound surface nursing powder for treating bedsore | |
| CN1191085C (en) | Quick-acting ointment for treating burns, scalds and knife wound | |
| CN1068213C (en) | Medicine for treating hyperosteogeny, and lumbage and leg pain | |
| CN105233265A (en) | Composition capable of promoting wound healing | |
| CN101810668A (en) | Toxin drawing plaster | |
| CN1994457B (en) | Swelling-relieving pain-stopping externally applied ointment | |
| CN103127274A (en) | All-season burn and scald medicine for seasons | |
| CN108283670A (en) | A kind of pharmaceutical composition and preparation method thereof for treating burn and scald | |
| CN114699455A (en) | Medicine for treating non-healing burn and scald and preparation method thereof | |
| Zhang et al. | Analysis of combined therapy and treatment effect of localized ultraviolet irradiation and Shengji Yuhong cream on diabetic foot | |
| CN103893422A (en) | Drug for repairing skin injury and preparation method of drug | |
| CN105233262A (en) | Ointment capable of promoting wound healing | |
| CN112353921A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
| CN1152702C (en) | Chinese medicine for treating bone tuberculosis, osteomyelitis, phlebitis and organism ulceration | |
| CN114288345A (en) | Medicine for treating burn and scald and its preparing method | |
| CN104474212A (en) | Traditional Chinese medicine anaesthesia solution for relieving pain in molluscum treatment | |
| CN112717042A (en) | A topical Chinese medicinal anesthetic and its preparation method | |
| CN113384678A (en) | External traditional Chinese medicine composition for promoting blood circulation to remove blood stasis and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |